Intercept Pharmaceuticals Inc ICPT

NAS: ICPT | ISIN: US45845P1084 7/11/2023

19,00 USD (+0,21%)

(+0,21%) 7/11/2023

Grafiek Intercept Pharmaceuticals Inc

Grafiek Intercept Pharmaceuticals Inc

1 dag1d 0,21%
1 week1w 0,00%
1 maand1m 0,00%
3 maanden3m 0,00%
6 maanden6m 0,96%
1 jaar1j 0,21%
5 jaar5j -79,01%

Intercept Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

24 oktober 2023 · SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTA, SPLK, ICPT, FNCB · Persbericht

24 oktober 2023 · ALERT: The M&A Class Action Firm Continues Investigating the Merger - ORTX, SRT, CHS, ICPT · Persbericht

20 oktober 2023 · Moore Kuehn Encourages ICPT, SRT, PCTI, and SP Investors to Contact Law Firm · Persbericht

19 oktober 2023 · SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMTI, ICPT, FNCB · Persbericht

10 oktober 2023 · SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMTI, CHS, FNCB, ICPT · Persbericht

10 oktober 2023 · SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - SATS, ICPT, AMNB, CHS · Persbericht

4 oktober 2023 · SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPLK, ICPT, CHS, AMTI · Persbericht

4 oktober 2023 · Moore Kuehn Encourages AMTI, SPLK, ICPT, and CHS Investors to Contact Law Firm · Persbericht

26 september 2023 · SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICPT, PFSW, AVTA, CATC · Persbericht

26 september 2023 · Shareholder Alert: Ademi LLP investigates whether Intercept Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Alfasigma · Persbericht

Profiel Intercept Pharmaceuticals Inc

Fabricage van farmaceutische preparaten

Farmaceutische producten: Andere

Gezondheidstechnologie

Werknemers: 484

Aandelen Intercept Pharmaceuticals Inc

Effecten: 41,83 miljoen

Winst per aandeel (12 maand): PLUS

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe